MYCN and neuroblastoma: Taken together, the data demonstrate that PRKCQ‐AS1 interacts with MSI2 to enhance BMX expression, resulting in ERK protein phosphorylation and MYCN nonamplified neuroblastoma tumorigenesis, and that PRKCQ‐AS1 and MSI2 interaction is a valid therapeutic target.